EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flick, M. J.
Right arrow Articles by Degen, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flick, M. J.
Right arrow Articles by Degen, J. L.
Experimental Biology and Medicine 229:1105-1110 (2004)
© 2004 Society for Experimental Biology and Medicine


SYMPOSIA

Fibrin(ogen)-{alpha}Mß2 Interactions Regulate Leukocyte Function and Innate Immunity In Vivo

Matthew J. Flick, Xinli Du and Jay L. Degen1

Children’s Hospital Research Foundation and the University of Cincinnati College of Medicine, Cincinnati, Ohio 45229

To whom requests for reprints should be addressed at 1 Children’s Hospital Research Foundation, Developmental Biology ML7007, CHRF Rm. 2042, 3333 Burnet Ave., Cincinnati, OH 45229–3039. E-mail: degenjl{at}cchmc.org

In addition to its well-characterized role in hemostasis, fibrin(ogen) has been proposed to be a central regulator of the inflammatory response. Multiple in vitro studies have demonstrated that this hemostatic factor can alter leukocyte function, including cell adhesion, migration, cytokine and chemokine expression, degranulation, and other specialized processes. One important link between fibrin(ogen) and leukocyte biology appears to be the integrin receptor {alpha}Mß2/Mac-1, which binds to immobilized fibrin(ogen) and regulates leukocyte activities. Although it is well established that fibrin(ogen) is a ligand for {alpha}Mß2, the precise molecular determinants that govern this interaction are only now becoming clear. A novel line of mice expressing a mutant form of fibrinogen (Fib{gamma}390–396A) has revealed that {gamma} chain residues 390–396 are important for the high-affinity engagement of fibrinogen by {alpha}Mß2 and leukocyte unction in vivo. Fibrinogen {gamma}390–396A failed to support {alpha}Mß2-mediated adhesion of primary neutrophils, monocytes, and macrophages, and mice expressing this fibrinogen variant were found to exhibit a major defect in the host inflammatory response following acute challenges. Most notably, Fib{gamma}390–396A mice display a profound impediment in Staphylococcus aureus elimination by leukocytes following intraperitoneal inoculation. These findings have positively established the physiological importance of fibrin(ogen) as a ligand for {alpha}Mß2 and illustrate that the fibrin(ogen) {gamma} chain residues 390–396 constitute a critical feature of the {alpha}Mß2 binding motif. Finally, the Fib{gamma}390–396A mice represent a valuable system for better defining the contribution of fibrin(ogen) to the inflammatory response in the absence of any confounding alteration in clotting function.

Key Words: coagulation • integrin • inflammation • innate immunity




This article has been cited by other articles:


Home page
J. Exp. Med.Home page
R. A. Adams, J. Bauer, M. J. Flick, S. L. Sikorski, T. Nuriel, H. Lassmann, J. L. Degen, and K. Akassoglou
The fibrin-derived {gamma}377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease
J. Exp. Med., March 19, 2007; 204(3): 571 - 582.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society for Experimental Biology and Medicine.